Will the FDA approve gedatolisib for advanced breast cancer?
Will the FDA approve gedatolisib for advanced breast cancer? Live odds across 5 markets: Before Jul 1, 2027 at 84¢. Resolves Jul 1, 2027. Not financial advice.
Resolves Jul 1, 2027
- Before Aug 1, 2026: Yes 70¢ (kalshi)
- Before Jul 1, 2026: Yes 18¢ (kalshi)
- Before Oct 1, 2026: Yes 69¢ (kalshi)
- Before Jan 1, 2027: Yes 74¢ (kalshi)
- Before Jul 1, 2027: Yes 84¢ (kalshi)
LIVE
8sWill the FDA approve gedatolisib for advanced breast cancer?
Resolves Jul 1, 2027
Total Volume
$6.5K
+$307 (24h)
Active Markets
5
Across 1 platforms
Frontrunner
81¢
Before Jul 1, 2027
Biggest Mover 24h
-4¢
Before Aug 1, 2026
Arb Opportunities
0
None detected
All Markets
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 81¢ | 84¢ | $87 | -4¢ | — | |
| 2 | 72¢ | 74¢ | $69 | -2¢ | — | |
| 3 | 67¢ | 70¢ | $3.4K+$304 24h | -4¢ | — | |
| 4 | 66¢ | 69¢ | $426 | -3¢ | — | |
| 5 | 17¢ | 18¢ | $2.5K+$3 24h | -4¢ | — |
Implied Probability
Consensus across platformsPrice History
Event Info
Whale Activity
Loading...